128 related articles for article (PubMed ID: 12474491)
1. The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers.
Satti I; el Hassan A; Khalil el TA; Akuffo H
Trans R Soc Trop Med Hyg; 2002; 96(5):565-7. PubMed ID: 12474491
[TBL] [Abstract][Full Text] [Related]
2. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
[TBL] [Abstract][Full Text] [Related]
3. A review of the leishmanin skin test: A neglected test for a neglected disease.
Carstens-Kass J; Paulini K; Lypaczewski P; Matlashewski G
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009531. PubMed ID: 34292942
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test.
De Luca PM; Mayrink W; Santiago MA; Nogueira R; Conceição-Silva F; Mélo G; Mendonça SC
Trans R Soc Trop Med Hyg; 2003; 97(6):709-12. PubMed ID: 16117969
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis.
De Luca PM; Mayrink W; Pinto JA; Coutinho SG; Santiago MA; Toledo VP; Costa CA; Genaro O; Reis AB; Mendonça SC
Acta Trop; 2001 Dec; 80(3):251-60. PubMed ID: 11700183
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testing.
Akuffo H; Darce M; Maasho K; Berhan TY
Am J Trop Med Hyg; 1995 Jul; 53(1):16-22. PubMed ID: 7625529
[TBL] [Abstract][Full Text] [Related]
7. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.
Sassi A; Louzir H; Ben Salah A; Mokni M; Ben Osman A; Dellagi K
Clin Exp Immunol; 1999 Apr; 116(1):127-32. PubMed ID: 10209516
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis.
Sadeghian G; Momeni A; Siadat AH; Yousefi P
Dermatol Online J; 2006 Dec; 12(7):3. PubMed ID: 17459289
[TBL] [Abstract][Full Text] [Related]
9. Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.
Alimohammadian MH; Jones SL; Darabi H; Riazirad F; Ajdary S; Shabani A; Rezaee MA; Mohebali M; Hosseini Z; Modabber F
Am J Trop Med Hyg; 2012 Jul; 87(1):70-5. PubMed ID: 22764294
[TBL] [Abstract][Full Text] [Related]
10. Use of Leishmania major derived leishmanin for skin test surveys of visceral leishmaniasis in Ethiopia.
Hailu A; Berhe N; Ali A; Gemetchu T
East Afr Med J; 1997 Jan; 74(1):41-5. PubMed ID: 9145577
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a standardized leishmanin skin test in Guatemala.
Arana BA; Roca M; Rizzo NR; Mendoza CE; Kroeger A
Trans R Soc Trop Med Hyg; 1999; 93(4):394-6. PubMed ID: 10674085
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection.
Schnorr D; Muniz AC; Passos S; Guimaraes LH; Lago EL; Bacellar O; Glesby MJ; Carvalho EM
PLoS Negl Trop Dis; 2012; 6(12):e1947. PubMed ID: 23285304
[TBL] [Abstract][Full Text] [Related]
13. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of two leishmanins in asymptomatic dogs.
Solano-Gallego L; Llull J; Arboix M; Ferrer L; Alberola J
Vet Parasitol; 2001 Dec; 102(1-2):163-6. PubMed ID: 11705662
[TBL] [Abstract][Full Text] [Related]
15. Response to heterologous leishmanins in cutaneous leishmaniasis in Nigeria--discovery of a new focus.
Agwale SM; Duhlinska DD; Grimaldi Júnior G
Mem Inst Oswaldo Cruz; 1998; 93(1):23-7. PubMed ID: 9698838
[TBL] [Abstract][Full Text] [Related]
16. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
Khalil EA; Elhassan AM; Zijlstra EE; Osman OF; Eljack IA; Ibrahim ME; Mukhtar MM; Ghalib HW; Modabbers F
East Afr Med J; 2000 Sep; 77(9):468-70. PubMed ID: 12862135
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptors 2, 4, and 7, Interferon-Gamma, Interleukin 10, and Programmed Death Ligand 1 Transcripts in Leishmanin Skin Test-Positive Reactions of Ibizan Hound Dogs.
Ordeix L; Montserrat-Sangrà S; Martínez-Orellana P; Solano-Gallego L
J Immunol Res; 2020; 2020():9602576. PubMed ID: 32211445
[TBL] [Abstract][Full Text] [Related]
19. Skin reactivity to thimerosal and phenol-preserved Montenegro antigen in Brazil.
Fagundes A; Marzochi MC; Perez M; Schubach A; Ferreira A; Silva JP; Schubach T; Marzochi KB
Acta Trop; 2007 Jan; 101(1):25-30. PubMed ID: 17227669
[TBL] [Abstract][Full Text] [Related]
20. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.
Mahmoodi M; Khamesipour A; Dowlati Y; Rafati S; Momeni AZ; Emamjomeh M; Hejazi H; Modabber F
Clin Exp Immunol; 2003 Nov; 134(2):303-8. PubMed ID: 14616791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
